Showing results (101-110 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|February 27, 2009
Human mitochondrial Mrs2 protein promotes multidrug resistance in gastric cancer cells by regulating p27, cyclin D1 expression and cytochrome C releaseYu Chen, Xufeng Wei, Pengfei Yan, et al.Cancer Biology & Therapy|February 27, 2009
ON-III inhibits erbB-2 tyrosine kinase receptor signal pathway and triggers apoptosis through induction of Bim in breast cancer cellsDan-Dan Li, Xiao-Qi Wu, Jun Tang, et al.Cancer Biology & Therapy|May 22, 2009
Silencing of focal adhesion kinase by tumor direct injection of small interfering RNA decreases in vivo tumor growthKae Tsutsumi, Takeshi Yamaura, Motowo Nakajima, et al.Cancer Biology & Therapy|July 15, 2009
Downregulation of a mitochondria associated protein SLP-2 inhibits tumor cell motility, proliferation and enhances cell sensitivity to chemotherapeutic reagentsYueqi Wang, Wenfeng Cao, Zaicheng Yu, et al.Cancer Biology & Therapy|February 17, 2012
Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cellsTsuyoshi Ohta, Toshifumi Takahashi, Tae Shibuya, et al.Cancer Biology & Therapy|February 17, 2012
Inhibiting homologous recombination for cancer therapySophia B Chernikova, John C Game, J Martin BrownCancer Biology & Therapy|February 17, 2012
Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesisYoun-Sun Lee, Kyeong-Mi Choi, Seunghyun Lee, et al.Cancer Biology & Therapy|January 13, 2012
Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growthBarbara Chiavarina, Diana Whitaker-Menezes, Ubaldo E Martinez-Outschoorn, et al.Cancer Biology & Therapy|January 13, 2012
PERP gene therapy attenuates lung cancer xenograft via inducing apoptosis and suppressing VEGFKe Chen, Zhaoyang Luo, Zhongwu Li, et al.Cancer Biology & Therapy|January 13, 2012
HDAC inhibitor sodium butyrate sensitizes E1A+Ras-transformed cells to DNA damaging agents by facilitating formation and persistence of γH2AX fociMaria V Abramova, Svetlana B Svetlikova, Alexander N Kukushkin, et al.Pageof 387